Legend Biotech Corporation announced that at the annual general meeting of shareholders held on October 14, 2022, elected Mr. Philip Yau as a Class II director for a three year term.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.54 USD | -0.07% | +13.76% | -24.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.31% | 8.31B | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.47% | 16.37B | |
+2.23% | 13.58B | |
+27.13% | 11.66B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Legend Biotech Corporation Elects Philip Yau as Director